830 breast cancer survivors share their quality of life after treatment
NCT ID NCT03859453
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study followed 830 women who had early or locally advanced breast cancer and finished their main treatment (except hormone therapy). The goal was to understand their health-related quality of life using several questionnaires. No new treatment was tested; instead, researchers gathered information to improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assistance Publique Hopitaux Paris - Assistance Publique - Hopitaux de Paris - Hopital Tenon
Paris, De, France
-
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy
-
Barts Health NHS Trust - St. Bartholomew'S Hospital
London, United Kingdom
-
C.H.U. Sart-Tilman
Liège, Belgium
-
CHU Saint Pierre - CHU Saint-Pierre-Site Porte de Hal
Brussels, Belgium
-
CHU-UCL Namur - CHU Site Sainte-Elisabeth-UCL Namur
Namur, Belgium
-
Clinica Universidad de Navarra
Madrid, Spain
-
Cliniques Universitaires Saint-Luc
Brussels, Belgium
-
Complejo Hospitalario de Navarra
Pamplona, Spain
-
Group Of Private Clinics Hirslanden - Hirslanden Klinik-Tumor Zentrum Aarau
Aarau, Switzerland
-
Groupe Radiopole Artois - Centre de radiotherapie Marie Curie
Arras, France
-
HELIOS Kliniken - Helios Klinikum Wuppertal - Klin. Univ. Witten / Herdecke
Wuppertal, Germany
-
Hospital Universitario Ramon y Cajal
Madrid, Spain
-
Hospital Universitario Reina Sofia
Córdoba, Spain
-
IRCCS - Fondazione G. Pascale
Naples, Italy
-
IRCCS - Istituto Oncologico Veneto
Padova, Italy
-
King Hussein Cancer Center
Amman, Jordan
-
Leeds Teaching Hospitals NHS Trust - St. James's University Hospital
Leeds, United Kingdom
-
Maria Sklodowska-Curie Memorial Cancer Centre - Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, Poland
-
Medical University Of Gdansk
Gdansk, Poland
-
Onze Lieve Vrouw Ziekenhuis
Aalst, Belgium
-
Ospedale Generale Regionale
Bolzano, Italy
-
Ospedale San Gerardo
Monza, Italy
-
The Great Poland Cancer Centre
Poznan, Poland
-
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis
Amsterdam, Netherlands
-
Tumor and Breast Center ZeTuP St. Gallen
Sankt Gallen, 9006, Switzerland
-
Universita Di Roma La Sapienza - Universita Degli Studi Di Roma La Sapienza - Ospedale Sant'Andrea
Roma, Italy
-
Universitaetsklinikum Leipzig-Klinik fuer Strahlentherapie und Radioonkologie
Leipzig, Germany